National Scleroderma Foundation

Analysis

National Scleroderma Foundation is a registered charity in United States, based in Danvers, MA. It received its IRS tax-exemption ruling in January 1985, 41 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, National Scleroderma Foundation reported income of $6.9m and spending of $6.5m, spending 93% of its income. Across the 4 years on record, from June 2020 to June 2023, income grew from $3.8m to $6.9m (+81%), an average of +22% a year. The sharpest change came in the year to June 2023, when income rose by 51%. Over the whole period it spent 114% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, National Scleroderma Foundation sits at the 81st percentile: it is larger than about 81% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 93rd percentile within MA. Charities of a similar size with the same main cause include Helping Hands Re-Entry Outreach Centers ($6.9m), The Huntsville Hospital Foundation Inc ($6.9m) and Rogue Retreat ($6.9m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 88% of the total. Compensation of current officers, directors and key employees was $455k (7.0% of expenses). Other salaries and wages came to $1.8m. At year end it held assets of $12.9m against liabilities of $3.1m, net assets of $9.8m. It reported 33 employees.